DK3126373T3 - Fremgangsmåde til fremstilling af amg 416 - Google Patents

Fremgangsmåde til fremstilling af amg 416 Download PDF

Info

Publication number
DK3126373T3
DK3126373T3 DK15773570.5T DK15773570T DK3126373T3 DK 3126373 T3 DK3126373 T3 DK 3126373T3 DK 15773570 T DK15773570 T DK 15773570T DK 3126373 T3 DK3126373 T3 DK 3126373T3
Authority
DK
Denmark
Prior art keywords
amg
procedure
manufacturing
manufacturing amg
Prior art date
Application number
DK15773570.5T
Other languages
English (en)
Inventor
Jeroen Bezemer
Ying Chen
Richard Crockett
Sheng Cui
Liang Huang
Sian Jones
Asher Lower
Krishnakumar Ranganathan
Kevin Crossley
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54241346&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3126373(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK3126373T3 publication Critical patent/DK3126373T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1075General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/20Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
DK15773570.5T 2014-04-03 2015-04-03 Fremgangsmåde til fremstilling af amg 416 DK3126373T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461974899P 2014-04-03 2014-04-03
PCT/US2015/024347 WO2015154031A1 (en) 2014-04-03 2015-04-03 Method for preparing amg 416

Publications (1)

Publication Number Publication Date
DK3126373T3 true DK3126373T3 (da) 2020-05-04

Family

ID=54241346

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15773570.5T DK3126373T3 (da) 2014-04-03 2015-04-03 Fremgangsmåde til fremstilling af amg 416

Country Status (27)

Country Link
US (3) US10407464B2 (da)
EP (3) EP3708576B1 (da)
JP (1) JP6710158B2 (da)
KR (1) KR102397271B1 (da)
CN (1) CN106795201A (da)
AU (1) AU2015240527B2 (da)
BR (1) BR112016022868A2 (da)
CA (1) CA2944194C (da)
CL (1) CL2016002513A1 (da)
CY (1) CY1123100T1 (da)
DK (1) DK3126373T3 (da)
EA (1) EA032597B1 (da)
ES (2) ES2786225T3 (da)
HR (1) HRP20200527T1 (da)
HU (1) HUE048489T2 (da)
IL (1) IL248059B2 (da)
LT (1) LT3126373T (da)
MA (2) MA39628B1 (da)
ME (1) ME03781B (da)
MX (1) MX2016012965A (da)
PL (1) PL3126373T3 (da)
PT (1) PT3126373T (da)
RS (1) RS60187B1 (da)
SG (1) SG11201608176VA (da)
SI (1) SI3126373T1 (da)
WO (1) WO2015154031A1 (da)
ZA (1) ZA201606844B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3013318B1 (en) 2013-06-28 2017-04-19 Amgen Inc. Stable liquid formulation of amg 416 (velcalcetide)
HUE048489T2 (hu) 2014-04-03 2020-07-28 Amgen Inc Eljárás AMG 416 elõállítására
CN106928321B (zh) * 2015-12-31 2019-07-26 深圳翰宇药业股份有限公司 一种合成Etelcalcetide的方法
CN106928320B (zh) * 2015-12-31 2021-01-15 深圳翰宇药业股份有限公司 一种合成Etelcalcetide的方法
CN109641946A (zh) * 2016-03-23 2019-04-16 巴切姆股份公司 胰高血糖素样肽的制备方法
US10858390B2 (en) * 2016-09-02 2020-12-08 Cem Corporation Use of excess carbodiimide for peptide synthesis at elevated temperatures
CN108101959B (zh) * 2016-11-24 2021-07-09 四川科伦药物研究院有限公司 一种制备高纯度多肽或其类似物的方法
CN106928171B (zh) * 2017-05-03 2019-08-13 成都郑源生化科技有限公司 Fmoc-Arg(Pbf)-OH的合成方法
TW201915009A (zh) * 2017-10-03 2019-04-16 中化合成生技股份有限公司 合成依特卡肽(Etelcalcetide)或其鹽類之方法
CN110498835B (zh) * 2018-05-17 2021-06-08 深圳翰宇药业股份有限公司 一种合成etelcalcetide的方法
CN109280078B (zh) * 2018-10-30 2019-06-25 成都诺和晟泰生物科技有限公司 一种制备维拉卡肽的方法
CN112062811B (zh) * 2019-06-10 2022-03-25 深圳翰宇药业股份有限公司 一种维拉卡肽的合成方法
US20220298206A1 (en) * 2019-08-26 2022-09-22 Auro Peptides Ltd An improved process for the preparation of Etelcalcetide Hydrochloride
EP3875466A1 (en) * 2020-03-05 2021-09-08 Fresenius Kabi iPSUM S.r.l. Process for the synthesis of etelcalcetide
US20230295221A1 (en) 2020-06-03 2023-09-21 Chugai Seiyaku Kabushiki Kaisha Efficient peptide condensation method for difficult sequences
CN111925415A (zh) * 2020-08-10 2020-11-13 海南中和药业股份有限公司 一种维拉卡肽杂质的制备方法
TWI792442B (zh) * 2021-07-23 2023-02-11 建誼生技股份有限公司 依特卡肽鹽酸鹽之製造方法
CN114524860A (zh) * 2021-12-29 2022-05-24 深圳翰宇药业股份有限公司 一种Etelcalcetide的合成方法及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941763A (en) 1975-03-28 1976-03-02 American Home Products Corporation PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates
EP0339695A3 (en) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates
SE9603465D0 (sv) 1996-09-23 1996-09-23 Astra Ab New compounds
NO311807B1 (no) * 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV
CA2703113A1 (en) 2007-10-27 2009-04-30 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
CN101250172B (zh) 2008-03-07 2012-05-02 上海瀚鸿化工科技有限公司 精氨酸双保护制备工艺
CA2761265C (en) 2009-05-06 2017-12-19 Mallinckrodt Llc Solid support for fmoc-solid phase synthesis of peptide acids
ES2607954T3 (es) 2009-07-29 2017-04-04 Kai Pharmaceuticals, Inc. Agentes terapéuticos para reducir los niveles de hormona paratiroidea
WO2011133346A1 (en) * 2010-04-21 2011-10-27 Pharmacofore, Inc. Peripheral opioid agonists and peripheral opioid antagonists
EP2614076A4 (en) * 2010-09-08 2014-03-05 Florey Howard Inst MODIFIED RELAXIN POLYPEPTIDES
WO2013042129A1 (en) 2011-09-23 2013-03-28 Natco Pharma Limited Improved process for preparation of bivalirudin
EP3013318B1 (en) 2013-06-28 2017-04-19 Amgen Inc. Stable liquid formulation of amg 416 (velcalcetide)
HUE048489T2 (hu) 2014-04-03 2020-07-28 Amgen Inc Eljárás AMG 416 elõállítására
CN105504012A (zh) * 2014-09-30 2016-04-20 深圳翰宇药业股份有限公司 一种多肽的制备方法
CN107434820A (zh) * 2017-08-07 2017-12-05 南京工业大学 一种维拉卡肽的合成方法

Also Published As

Publication number Publication date
EP4219526A2 (en) 2023-08-02
CL2016002513A1 (es) 2018-03-23
SG11201608176VA (en) 2016-10-28
ME03781B (me) 2021-04-20
EA201692001A1 (ru) 2017-02-28
US20190352336A1 (en) 2019-11-21
ES2943671T3 (es) 2023-06-15
IL248059A0 (en) 2016-11-30
EP3126373A1 (en) 2017-02-08
MA52906A (fr) 2021-04-21
EP4219526A3 (en) 2023-08-30
RS60187B1 (sr) 2020-06-30
EP3708576B1 (en) 2023-02-22
US11377474B2 (en) 2022-07-05
CA2944194A1 (en) 2015-10-08
WO2015154031A1 (en) 2015-10-08
ES2786225T3 (es) 2020-10-09
MA39628B1 (fr) 2020-05-29
AU2015240527A1 (en) 2016-10-20
JP6710158B2 (ja) 2020-06-17
US20170190739A1 (en) 2017-07-06
US10407464B2 (en) 2019-09-10
EP3126373B1 (en) 2020-03-04
CN106795201A (zh) 2017-05-31
KR102397271B1 (ko) 2022-05-16
EA032597B1 (ru) 2019-06-28
EP3126373A4 (en) 2018-06-20
MX2016012965A (es) 2017-07-06
US20230099078A1 (en) 2023-03-30
AU2015240527B2 (en) 2019-09-26
ZA201606844B (en) 2018-07-25
JP2017511332A (ja) 2017-04-20
CY1123100T1 (el) 2021-10-29
BR112016022868A2 (pt) 2018-07-03
PT3126373T (pt) 2020-04-24
IL248059B2 (en) 2023-10-01
LT3126373T (lt) 2020-05-11
HRP20200527T1 (hr) 2020-06-26
EP3708576A1 (en) 2020-09-16
KR20170026326A (ko) 2017-03-08
HUE048489T2 (hu) 2020-07-28
IL248059B1 (en) 2023-06-01
SI3126373T1 (sl) 2020-06-30
PL3126373T3 (pl) 2020-07-27
CA2944194C (en) 2022-04-19

Similar Documents

Publication Publication Date Title
FIC20230006I1 (fi) Vutrisiraani
DK3405050T3 (da) Børnesikret snusbeholder
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3126373T3 (da) Fremgangsmåde til fremstilling af amg 416
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3294700T3 (da) Fremgangsmåde til fremstilling af limonen-4-ol
DK3072835T3 (da) Fremgangsmåde til fremføring
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3436823T3 (da) Antigen-array
DK3507408T3 (da) Fremgangsmåde til fremstilling af nonwoven
DK3125898T3 (da) Farmakofor til trail-induktion
DK3445708T3 (da) Stigbøjle
DK3402792T3 (da) Quinolin-2-on-derivater
DK3529233T3 (da) Fremgangsmåde til fremstilling af 3-alkylsulfanyl-2-chlor-n-(1-alkyl-1h-tetrazol-5-yl)-4-trifluoromethyl-benzamider
DK3335532T3 (da) Tandharve
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3509963T3 (da) Pallecontainer
DK3438103T3 (da) Griseofulvinforbindelse
DK3528829T3 (da) Bacitracin-alginat-oligomer-konjugater
DK3507282T3 (da) Fremgangsmåde til fremstilling af indolcarboxamidforbindelser
DK3148993T3 (da) Fremgangsmåde til fremstilling af thiazolderivater
DK3149422T3 (da) Anordning til fremstilling af cementklinker
DE112017006386A5 (de) Schraubarbeitszylinder
DE112017000734A5 (de) Glycolsensor